$AGL News

Barclays Upgrades agilon health (AGL)

Barclays Upgrades Agilon Health to Equal-Weight, Announces $81 Price Target

Benchmark Maintains Buy on Agilon Health, Lowers Price Target to $95

agilon health (AGL) Price Target Increased by 50.63% to 30.22

TD Cowen Maintains Hold on Agilon Health, Raises Price Target to $55

What's Going On With Agilon Health Stock Friday?

Wells Fargo Maintains Overweight on Agilon Health, Raises Price Target to $72

Deutsche Bank Upgrades agilon health (AGL)

Jefferies Upgrades agilon health (AGL)

Agilon Health Operational Initiatives Begin Showing Results

Evercore ISI Group Maintains In-Line on Agilon Health, Raises Price Target to $32

Jefferies Upgrades Agilon Health to Buy, Raises Price Target to $48

Baird Maintains Neutral on Agilon Health, Raises Price Target to $35

Deutsche Bank Upgrades Agilon Health to Buy, Raises Price Target to $49

agilon health, inc. (AGL) Q1 2026 Earnings Call Transcript

Agilon Health Inc (NYSE:AGL) Swings to Profit, Crushes Q1 Estimates, Sends Shares Soaring

Agilon Health Raises FY2026 Sales Guidance from $5.410B-$5.580B to $5.680B-$5.805B vs $5.452B Est

Agilon Health Sees Q2 Sales $1.435B-$1.475B vs $1.343B Est

CORRECTION: Agilon Health Q1 EPS $1.80 Beats $1.31 Estimate, Sales $1.420B Beat $1.380B Estimate

JP Morgan Downgrades agilon health (AGL)